Abstract: A method for fixation of biological tissues, and bioprosthetic devices prepared by such method. The method generally comprises the steps of A) fixing the tissue, B) treating the tissue with a mixture of i) a denaturant, ii) a surfactant and iii) a crosslinking agent, C) fabricating or forming the bioprosthesis (e.g., forming the tissue and attaching any non-biological components thereto) and D) subjecting the bioprosthesis to terminal sterilization.
Type:
Grant
Filed:
April 6, 2001
Date of Patent:
April 15, 2003
Assignee:
Edwards Lifesciences Corporation
Inventors:
Alain F. Carpentier, Sophie Carpentier, Crystal M. Cunanan, Lillian Quintero, Michael N. Helmus, Christine Loshbaugh, H. Chris Sarner
Abstract: Leather is tanned by cross-linking collagen with tris(hydroxymethyl)phosphine or a condensate of a tetrakis(hydroxymethyl)phosphonium salt with an amide or amine in a main tannage or retannage.
Type:
Grant
Filed:
April 14, 2000
Date of Patent:
April 1, 2003
Assignee:
Rhodia Consumer Specialties Limited
Inventors:
Gareth Rhys Collins, Christopher Raymond Jones, Robert Eric Talbot, Jane Williams, Mohsen Zakikhani
Abstract: A graft prostheses (11), materials and method for implanting, transplanting, replacing, or repairing a part of a patient. The graft prosthesis includes a purified, collagen-based matrix structure removed from a submucosa tissue source. The submucosa tissue source is purified by disinfection and removal steps to deactivate and remove contaminants, thereby making the purified structure biocompatible and suitable for grafting on and/or in a patient.
Type:
Application
Filed:
March 2, 2001
Publication date:
March 6, 2003
Inventors:
William A. Cook, Michael C. Hiles, Thomas G. Kozma, Umesh H. Patel
Abstract: An apparatus (10) for grafting of a blood vessel (12) and a method of forming the apparatus (10) is provided. The apparatus (10) comprises an expandable support member (16) having inner and outer surfaces (36 and 34). The outer surface (34) of the expandable support member (16) is for engaging and adhering to an inside surface (68) of the blood vessel (12). A layer of biological tissue (14) is attached to the inner surface (36) of the support member (16). The layer of biological tissue (14) has an uninterrupted inwardly facing surface (50) for extending confluently with the inside surface (68) of the blood vessel (12) to provide resistance to thrombosis and platelet deposition.
Abstract: The invention is directed to a method of debriding bone including incubating the bone and associated soft tissue, with one or more debriding solutions where the debriding solution may include one or more alkaline solutions. Incubation is optionally carried out with one or more debriding agents including inert dry granular or particulate material including for example beads, and the granular phase of an alkaline agent, including for example granular sodium hydroxide. The incubating may be carried out with agitation. In another embodiment, the medullary canal of the bone is subjected to a positive pressure stream of debriding solution under conditions sufficient to loosen the associated soft tissue from the bone at the interface of the soft tissue and bone. In a further embodiment, the debriding solution is provided as a gel.
Type:
Application
Filed:
March 27, 2002
Publication date:
January 16, 2003
Inventors:
Lloyd Wolfinbarger, Robert K. O'Leary, Louis Ford, Alyce Linhurst Jones
Abstract: This invention is directed to tissue engineered prostheses made from processed tissue matrices derived from native tissues that are biocompatible with the patient or host in which they are implanted. When implanted into a mammalian host, these prostheses can serve as a functioning repair, augmentation, or replacement body part or tissue structure.
Abstract: The invention provides an article of manufacture comprising a substantially non-immunogenic ligament or tendon xenograft for implantation into humans. The invention further provides a method for preparing a ligament xenograft by removing at least a portion of a ligament from a non-human animal to provide a xenograft; washing the xenograft in saline and alcohol; subjecting the xenograft to at least one treatment selected from the group consisting of exposure to ultraviolet radiation, immersion in alcohol, ozonation, freeze/thaw cycling, and optionally chemical crosslinking. In addition to or in lieu of the above treatments, the methods include a cellular disruption treatment and either digestion of the carbohydrate moieties of the xenograft with a glycosidase in a range of about 1 mU/ml to about 1000 U/ml or glycosidase digestion followed by treatment for sialylation. The invention also provides articles of manufacture produced by one or more of the above-identified methods of the invention.
Abstract: The invention involves a bioprosthetic article including a biocompatible material having at least one bound exogenous storage structure, the storage structures having collectively greater than about 0.5 mg metal cations per gram of biocompatible material. The calcification inhibitors preferably decrease calcium deposition by greater than 95% relative to untreated tissue. The calcification inhibitors are bonded to the bioprosthetic material preferably at a pH between about 6.0 and 8.5.
Abstract: The invention relates to an osteoimplant fabricated from a solid aggregate of bone derived elements possessing chemical linkages between their adjacent surface-exposed collagen. Also described are various other components which can be incorporated into the bone implant material such as bone-growth inducing substances; and a method of manufacture.
Abstract: A process for preparing pliable soft tissue specimen which are resistant to cracking and devoid of viable cells includes the steps of treating native soft tissue obtained from a donor by a gradually increasing gradient of aliphatic alcohol or other suitable water miscible polar organic solvent until the last alcohol (or other solvent) solution has at least 25% by volume of the organic liquid. Thereafter, the tissue specimen is treated with a solution containing glycerol or low molecular weight (<1000D) polyethylene glycol, and polyethylene glycol of a molecular weight between approximately 6,000 to 15,000 D and heparin. Thereafter, the tissue specimen is briefly immersed in aqueous heparin solution, frozen and lyophilized. The tissue specimen is suitable for implantation as a homograft or xenograft, with or without rehydration.
Type:
Application
Filed:
June 24, 1998
Publication date:
June 21, 2001
Inventors:
CARLOS M. G. DURAN, DAVID T. CHEUNG, DAVID C. PANG
Abstract: The present invention provides an epoxy compound that has a hydrocarbon backbone, that is water-soluble, and which does not contain an ether or ester linkage in its backbone. Examples of suitable epoxide agents include mono- or diepoxides that have the following basic formulas:
Monoepoxide:
Diepoxide:
where n=1 to 10.
Abstract: The present invention relates, in general, to tissue decellularization and, in particular to a method of treating tissues, for example, heart valves, tendons and ligaments, so as to render them acellular and thereby limit mineralization and/or immunoreactivity upon implementation in vivo.
Abstract: Aqueous solutions or dispersions of copolymers obtainable by free-radical copolymerization of
(a) from 20 to 90% by weight of at least one monoethylenically unsaturated C4-6-dicarboxylic acid or the anhydride thereof, as component A,
(b) from 5 to 50% by weight of at least one olefin having 2 to 6 carbon atoms, as component B,
(c) from 5 to 50% by weight of at least one hydrophobic comonomer from the group consisting of long-chain olefins, esters of long-chain alcohols with acrylic acid or methacrylic acid, long-chain amides of acrylic acid or methacrylic acid, and long-chain alkyl vinyl ethers, as component C,
(d) from 0 to 40% by weight of further comonomers which can be copolymerized with the above monomers, as component D,
where the sum of the amounts of components A, B, C and, if used, D is 100% by weight, followed by at least partial esterification or hydrolysis and neutralization and/or reaction of the carboxyl groups formed during the hydrolysis with bases, for treating leather and/or fur skins.
Type:
Grant
Filed:
November 9, 1998
Date of Patent:
March 13, 2001
Assignee:
BASF Aktiengesellschaft
Inventors:
Michael Kneip, Axel Kistenmacher, Peter Danisch, Gerhard Wolf